FUSION PROTEIN CAPABLE OF BINDING VEGF-A AND TNF-ALPHA
    2.
    发明申请
    FUSION PROTEIN CAPABLE OF BINDING VEGF-A AND TNF-ALPHA 有权
    融合蛋白能够结合VEGF-A和TNF-α

    公开(公告)号:US20100150926A1

    公开(公告)日:2010-06-17

    申请号:US12636013

    申请日:2009-12-11

    摘要: The present application describes an isolated nucleic acid molecule encoding a polypeptide capable of synchronously binding VEGF polypeptide and TNF polypeptide comprising: (a) a nucleotide sequence encoding a TNFR2 component and VEGFR1 component operatively linked to (b) a nucleotide sequence encoding a multimerizing component, wherein the TNFR2 component consists essentially of a nucleotide sequence encoding the amino acid sequences of cystein rich domain 1, cystein rich domain 2, cystein rich domain 3, and cystein rich domain 4 of the extracellular domain of TNFR2, and wherein the VEGFR1 component consists essentially of a nucleotide sequence encoding the amino acid sequences of Ig-like domain 2 of the extracellular domain of VEGFR1.

    摘要翻译: 本申请描述了编码能够同时结合VEGF多肽和TNF多肽的多肽的分离的核酸分子,其包含:(a)编码TNFR2组分的核苷酸序列和可操作地连接到(b)编码多聚化成分的核苷酸序列的VEGFR1组分, 其中TNFR2组分基本上由编码TNFR2细胞外结构域的富含半胱氨酸域1,半胱氨酸富含结构域2,半胱氨酸富含结构域3和半胱氨酸富含结构域4的氨基酸序列的核苷酸序列组成,其中VEGFR1组分基本上组成 的编码VEGFR1细胞外结构域的Ig样结构域2的氨基酸序列的核苷酸序列。

    Fusion protein capable of binding VEGF-A and TNF-alpha
    3.
    发明授权
    Fusion protein capable of binding VEGF-A and TNF-alpha 有权
    能够结合VEGF-A和TNF-α的融合蛋白

    公开(公告)号:US08927232B2

    公开(公告)日:2015-01-06

    申请号:US12636013

    申请日:2009-12-11

    摘要: The present application describes an isolated nucleic acid molecule encoding a polypeptide capable of synchronously binding VEGF polypeptide and TNF polypeptide comprising: (a) a nucleotide sequence encoding a TNFR2 component and VEGFR1 component operatively linked to (b) a nucleotide sequence encoding a multimerizing component, wherein the TNFR2 component consists essentially of a nucleotide sequence encoding the amino acid sequences of cystein rich domain 1, cystein rich domain 2, cystein rich domain 3, and cystein rich domain 4 of the extracellular domain of TNFR2, and wherein the VEGFR1 component consists essentially of a nucleotide sequence encoding the amino acid sequences of Ig-like domain 2 of the extracellular domain of VEGFR1.

    摘要翻译: 本申请描述了编码能够同时结合VEGF多肽和TNF多肽的多肽的分离的核酸分子,其包含:(a)编码TNFR2组分的核苷酸序列和可操作地连接到(b)编码多聚化成分的核苷酸序列的VEGFR1组分, 其中TNFR2组分基本上由编码TNFR2细胞外结构域的富含半胱氨酸域1,半胱氨酸富含结构域2,半胱氨酸富含结构域3和半胱氨酸富含结构域4的氨基酸序列的核苷酸序列组成,其中VEGFR1组分基本上组成 的编码VEGFR1细胞外结构域的Ig样结构域2的氨基酸序列的核苷酸序列。

    Inhibition of apoptosis by the expression of antisense RNA of caspase-3
    5.
    发明授权
    Inhibition of apoptosis by the expression of antisense RNA of caspase-3 失效
    通过caspase-3的反义RNA的表达抑制细胞凋亡

    公开(公告)号:US06943022B2

    公开(公告)日:2005-09-13

    申请号:US10245813

    申请日:2002-09-17

    摘要: The present invention relates to an antisense nucleotide of caspase-3, an expression vector encoding antisense RNA of caspase-3, and an inhibition method of cellular apoptosis in recombinant Chinese hamster ovary (CHO) cells using the same. More precisely, the present invention relates to an antisense nucleotide composed of a base sequence represented by Sequence ID No. 1, which suppresses the expression of caspase-3, an expression vector containing the above antisense nucleotide and expressing antisense RNA of caspase-3, and an inhibition method of apoptosis of recombinant cells by suppressing the expression of caspase-3 through introducing the above expression vector into the recombinant cells and then expressing antisense RNA of caspase-3. According to the present invention, apoptosis can be inhibited by suppressing the activation of caspase-3, which is related to the apoptosis, and the integrity of target protein produced in the recombinant cells can be enhanced.

    摘要翻译: 本发明涉及半胱天冬酶-3的反义核苷酸,编码半胱天冬酶-3的反义RNA的表达载体,以及使用其的重组中国仓鼠卵巢(CHO)细胞中的细胞凋亡的抑制方法。 更准确地说,本发明涉及由序列号1表示的碱基序列构成的反义核苷酸,其抑制半胱天冬酶-3的表达,含有上述反义核苷酸并表达半胱天冬酶-3的反义RNA的表达载体, 以及通过将上述表达载体导入重组细胞中,然后表达半胱天冬酶-3的反义RNA,通过抑制半胱天冬酶-3的表达来抑制重组细胞凋亡的抑制方法。 根据本发明,通过抑制与凋亡相关的半胱天冬酶-3的活化,可以抑制细胞凋亡,能够提高重组细胞中产生的靶蛋白的完整性。